Canadian Cardiovascular Society Sets New Guidelines for the Management and Treatment of Atrial Fibrillation (IMAGE)

Elsevier Health Sciences

Canadian Cardiovascular Society Sets New Guidelines for the Management and Treatment of Atrial Fibrillation

Caption

This is a summary of the recommendations for the management of antithrombotic therapy in patients with atrial fibrillation in association with Non-ST-elevation acute coronary syndrome or ST-elevation myocardial infarction. ASA, acetylsalicylic acid (aspirin); CHADS2, Congestive Heart Failure, Hypertension, Age, Diabetes, Stroke/Transient Ischemic Attack; NOAC, non-vitamin K antagonist oral anticoagulant; OAC, oral anticoagulant; PCI, percutaneous coronary intervention.

Credit

Canadian Cardiovascular Society

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.